By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported a 13 percent jump in revenues for the fourth quarter of 2010 to $483.6 million, compared to $428.8 million a year ago, and exceeding consensus analyst estimates of $464.83.

Driving revenues for the three months ended Dec. 31, 2010, was an increase in uptake of the company's new systems, continued expansion in Asia, and an improved overall economy, Douglas Berthiaume, chairman and CEO of Waters, said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.